The results of the angiogenesis arrays revealed that the OmAd-CM-treated cells showed higher gene expressions of VEGFA, IFNB, VEGFD and ANGPTL4 compared with the control cells, and revealed consistent results in both of the GC cell lines (Fig. 2k). The gene discussed is VEGFA; the disease is gastric cancer.